Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Interleukin 8 promoter polymorphism predicts the initial response to bevacizumab treatment for exudative age-related macular degeneration.

Retina (Philadelphia, Pa.) - 1 Oct 2013

Hautamäki Asta, Kivioja Jarno, Vavuli Satu, Kakko Sakari, Savolainen Eeva-Riitta, Savolainen Markku J, Liinamaa M Johanna, Seitsonen Sanna, Onkamo Päivi, Järvelä Irma, Immonen Ilkka

Abstract excerpt

PURPOSE: To study the association of single-nucleotide polymorphisms of interleukin 8, vascular endothelial growth factor, erythropoietin, complement factor H, complement component C3, and LOC387715 genes with the response to bevacizumab treatment in exudative age-related macular degeneration. METHODS: Clinical records, smoking history, optical coherence tomography, and angiographies of 96 bevacizumab-treated...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Angiogenesis Inhibitors
Share to Bevacizumab

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Complement C3

Share to Complement Factor H

Share to Exudates and Transudates

Share to Interleukin-8

Share to Intravitreal Injections

Share to Wet Macular Degeneration

Source

Identifiers

PMID: 23584701
DOI: 10.1097/IAE.0b013e318285cf92

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Interleukin 8 promoter polymorphism predicts the initial response to bevacizumab treatment for exudative age-related macular degeneration.PMID 23584701Read ↗

Exudative Age-Related Macular Degeneration: Association between Treatment Efficacy and Single-Nucleotide Variants in RAD51B, TRIB1, COL8A1, COL10A1, IL-9, IL-10, and VEGFA Genes.Semantic proximity Read ↗

IL-8 and VEGFR-2 polymorphisms modulate long-term functional response to intravitreal ranibizumab in exudative age-related macular degeneration.Semantic proximity Read ↗

Suggestive association between PLA2G12A single nucleotide polymorphism rs2285714 and response to anti-vascular endothelial growth factor therapy in patients with exudative age-related macular degeneration.Semantic proximity Read ↗

Role of vascular endothelial growth factor polymorphisms in the treatment success in patients with wet age-related macular degeneration.Semantic proximity Read ↗

VEGFA Haplotype and VEGF-A and VEGF-R2 Protein Associations with Exudative Age-Related Macular Degeneration.Semantic proximity Read ↗

Genetic biomarkers in the VEGF pathway predicting response to anti-VEGF therapy in age-related macular degenerationSemantic proximity Read ↗

Vascular endothelial growth factor gene variation and the response to photodynamic therapy in age-related macular degeneration.Semantic proximity Read ↗

Combined effects of genetic and non-genetic risk factors affect response to ranibizumab in exudative age-related macular degeneration.Semantic proximity Read ↗

VEGF-A polymorphisms predict short-term functional response to intravitreal ranibizumab in exudative age-related macular degeneration.Semantic proximity Read ↗

Association of complement factor H and LOC387715 genotypes with response of exudative age-related macular degeneration to intravitreal bevacizumab.Semantic proximity Read ↗

Pharmacogenetic association with early response to intravitreal ranibizumab for age-related macular degeneration in a Korean population.Semantic proximity Read ↗

Predicting non-response to ranibizumab in patients with neovascular age-related macular degeneration.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.